The comorbidity of gynecological diseases and non-psychotic mental disorders (NPMD) is a significant interdisciplinary issue characterized by mutual exacerbation. Currently, there is a lack of comprehensive research on the medical and social profiles of gynecological patients who have been diagnosed with NPMD and are receiving psychopharmacotherapy. This gap in understanding hinders the development of integrated diagnostic and treatment approaches. Objective. To compare the medical and social characteristics, as well as the patterns of somatic and gynecological comorbidity in gynecological patients, based on the presence of verified NPMD and considering their ongoing psychopharmacotherapy. Materials and Methods. This study was a single-center cross-sectional investigation involving 100 gynecological patients, with a median age of 33.5 years. The main group consisted of 50 patients diagnosed with non-psychotic mental disorders (NPMD), specifically coded as F32-F33, F40-F48, and F60, who had been receiving psychopharmacotherapy for at least four weeks. The comparison group also comprised 50 patients who did not have any mental disorders, as determined by a psychiatric interview and their medical history. We utilized structured questionnaires to gather information on socio-demographic data, smoking habits, anthropometric measurements, and to analyze medical records, which included gynecological and somatic diagnoses coded according to the ICD-10 system. For the statistical analysis, R version 4.3.1 was employed, utilizing the Mann-Whitney U test, Fisher's exact test, odds ratios (OR), and 95% confidence intervals (CI). Results. The groups exhibited comparable characteristics in terms of age (p = 0.156) and education (p = 0.279). The NPMD group demonstrated significantly higher rates of unmarried women (68% compared to 40%; OR=3.20; 95% CI 1.45–7.13; p = 0.006), unemployment (36% versus 18%; OR=2.56; 95% CI 1.02–6.45; p = 0.041), and active smokers (44% against 18%; OR=3.60; 95% CI 1.45–9.01; p = 0.006). No notable differences were observed in the prevalence of endometriosis or uterine fibroids. The reported incidence of benign breast diseases (BBD) was significantly lower in the NPMD group (32% versus 60%; OR = 0.31; 95% CI 0.14–0.70; p = 0.006). Somatic comorbidity was markedly higher in the primary group (86% compared to 62%; OR = 3.86; 95% CI 1.44–10.91; p = 0.009), largely attributed to functional gastrointestinal disorders (38% versus 14%; OR = 3.80; 95% CI 1.43–10.32; p = 0.008). Conclusion. Female patients in gynecology with comorbid non-psychotic mental disorders (NPMD) who are undergoing psychopharmacological treatment exhibit increased levels of social maladjustment, tobacco use, and multimorbidity, particularly with a notable prevalence of functional gastrointestinal conditions. The reduced incidence of benign breast disease (BBD) in this cohort necessitates careful interpretation and additional research that considers the frequency of screening and reproductive variables. The practicality of incorporating psychiatric evaluations into standard gynecological care is supported.